{
  "docId": "019de070-5bad-7209-9a4b-c2388bb12878",
  "docSlug": "45a794600ccc29f3eaf009a5452211e7",
  "documentTitle": "Codiak | IPO Presentation Deck | 36 slides",
  "authorId": "codiak",
  "authorName": "Codiak",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2020-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 23,
  "pageCount": 36,
  "prevPage": 22,
  "nextPage": 24,
  "slideType": "roadmap",
  "function": "plan_implementation",
  "density": "balanced",
  "nDataPoints": 6,
  "notes": "The slide outlines a standard oncology clinical trial structure with a 3+3 dose escalation design and specific target indications for expansion.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de070-5bad-7209-9a4b-c2388bb12878/23",
  "deckHref": "/decks/019de070-5bad-7209-9a4b-c2388bb12878",
  "deckJsonHref": "/decks/019de070-5bad-7209-9a4b-c2388bb12878.json",
  "deckAnchorHref": "/decks/019de070-5bad-7209-9a4b-c2388bb12878#slide-23",
  "components": [
    {
      "bbox": {
        "h": 0.15,
        "w": 0.94,
        "x": 0.03,
        "y": 0.78
      },
      "kind": "callout",
      "text": "EXPECTED FIRST DATA READOUT MID-2021: 1) Single agent pharmacological activity, dose selection 2) Tumor localized PD and T-cell recruitment 3) Cohort expansion into select tumor types",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "58f9c5fe-c37c-46a6-b442-9ded08feb688",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.55,
        "w": 0.55,
        "x": 0.03,
        "y": 0.21
      },
      "kind": "diagram",
      "text": "PART A - MULTIPLE DOSE ESCALATION, \"3+3\" DESIGN",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9db1c8df-c6ae-4486-892f-1f36cb3fa00b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.55,
        "w": 0.35,
        "x": 0.62,
        "y": 0.21
      },
      "kind": "table",
      "text": "PART B - EXPANSION COHORTS",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5c3760dc-3571-4a62-abdf-b9941161c0c3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.45,
        "x": 0.03,
        "y": 0.08
      },
      "kind": "title",
      "text": "exoSTING Phase 1/2 Trial Design and Data Flow",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "15fd90b1-f485-4af7-8ab5-b66916655ab2",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "clinical-trial-design",
      "slug": null,
      "matchId": "c1201093-dfcd-4f86-8cd4-863f0b19aaac",
      "evidence": "3+3 dose escalation and expansion cohort structure",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 35,
      "from": 16,
      "beatId": "87a4caff-9c60-44c7-b0ac-0079e1a8e9eb",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Roadmap",
      "beatSlug": null,
      "evidence": "Slides 16-35 outline Codiak's pipeline, clinical programs, and future plans",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}